Pharmacological Interactions on Blood Pressure Control in Arterial Hypertension, An Issue not to be Overlooked

Michele M Ciulla1, Chiara Benfenati, Enrico Gallazzi

  • 1Laboratory of Clinical Informatics and Cardiovascular Imaging, Via F. Sforza, 35 20122 Milan, Italy. michele.ciulla@unimi.it.

Insights

Long-term hypertension management requires continuous monitoring due to side effects and drug interactions. Addressing these challenges is crucial for preventing cardiovascular disease and organ damage.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Essential arterial hypertension management necessitates long-term strategies to prevent target organ damage and cardiovascular events.
  • Current treatment paradigms face challenges including achieving target blood pressure, managing drug side effects, and addressing adverse drug reactions in an aging population.

Purpose of the Study:

  • To evaluate the goals of antihypertensive therapy.
  • To identify weak spots in current strategies, including side effects and poor therapy compliance.
  • To review drug interactions impacting blood pressure control.

Main Methods:

  • Literature review of antihypertensive therapy goals and challenges.
  • Analysis of factors affecting treatment efficacy and patient compliance.
  • Examination of drug interactions relevant to hypertension management.

Main Results:

  • Achieving target blood pressure requires continuous monitoring and often combination therapies.
  • Chronic use of antihypertensives can lead to side effects and adverse drug reactions.
  • Drug interactions can interfere with blood pressure control and reduce treatment effectiveness.

Conclusions:

  • Long-term hypertension management requires ongoing adaptation of strategies.
  • Addressing side effects, compliance, and drug interactions is vital for effective cardiovascular risk reduction.
  • Further research is needed to optimize prevention strategies for target organ damage and mortality.

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
3.0K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.5K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.8K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
831